CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2006-05-12 | Hudson Leslie Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2006-05-12 | HARVEY RICHARD A JR Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2006-05-12 | FAHIM RAAFAT E F Sr. VP Tech. & Prod. | Grant or award | +40,000 | 90,312.43 | ||
| 2006-05-12 | DAVIS PETER B Director | Grant or award | +3,968 | $6.30 | $25K | 3,968 |
| 2006-05-12 | DAVIS PETER B Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2006-05-12 | CASTALDI DAVID L Director | Grant or award | +3,174 | $6.30 | $20K | 49,189 |
| 2006-05-12 | CASTALDI DAVID L Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2006-02-24 | RASMUSSEN HENRIK S MD Sr. VP Clin. Med. & Reg. Affs. | Grant or award | +37,859 | 40,689.05 | ||
| 2006-02-24 | RASMUSSEN HENRIK S MD Sr. VP Clin. Med. & Reg. Affs. | Grant or award · Stock Option (right to buy) | +54,345 | 54,345 | ||
| 2006-02-24 | Johnson Joseph Sr. VP, HR, IT, Bus. Strat. | Grant or award | +32,637 | 32,637 | ||
| 2006-02-24 | Johnson Joseph Sr. VP, HR, IT, Bus. Strat. | Grant or award · Stock Option (right to buy) | +46,849 | 46,849 | ||
| 2006-02-24 | MCLAIN THOMAS H Chairman, CEO & President | Grant or award | +58,746 | 102,257.27 | ||
| 2006-02-24 | MCLAIN THOMAS H Chairman, CEO & President | Grant or award · Stock Option (right to buy) | +84,329 | 84,329 | ||
| 2006-02-24 | FAHIM RAAFAT E F Sr. VP Tech. & Prod. | Grant or award | +37,859 | 50,312.43 | ||
| 2006-02-24 | FAHIM RAAFAT E F Sr. VP Tech. & Prod. | Grant or award · Stock Option (right to buy) | +54,345 | 54,345 | ||
| 2005-11-15 | MCLAIN THOMAS H Chairman, CEO & President | Other acquisition | +63,271.66 | $3.48 | $220K | 63,271.66 |
| 2005-11-08 | SMITH MARK L Sr. VP Fin., CFO, CAO & Treas. | Other acquisition | +17,393.17 | $3.52 | $61K | 17,393.17 |
| 2005-11-04 | Jooste H Le Roux Sr. VP, Glbl. Sales & Mktng. | Purchase | +10,000 | $3.55 | $36K | 10,000 |
| 2005-11-03 | FAHIM RAAFAT E F Sr. VP Tech. & Prod. | Purchase | +5,000 | $3.46 | $17K | 11,859.12 |
| 2005-08-18 | Hudson Leslie Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 |
Page 41 of 42 · 830 trades